Drug executives list pros, cons of health reform

11/18/2009 | Wall Street Journal, The

Health reform legislation could increase drug benefits and decrease the cost of medications, potentially improving the public's perception of the pharmaceutical industry, said Jane Horvath, Merck & Co.'s senior director of public policy. However, the bill could mean more contribution from the industry through "Medicaid-style rebates" and also compromise relationships with academic researchers, said Horvath, whose concerns were echoed by other drug executives at a biotech conference in Philadelphia.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ